PROTHENA CORPORATION PUBLIC LIMITED COMPANY Operating Leases, Future Minimum Payments, Due in Four Years
PROTHENA CORPORATION PUBLIC LIMITED COMPANY (PRTA) had Operating Leases, Future Minimum Payments, Due in Four Years of $0 as of 2018-12-31, per its 10-K filed 2020-03-03.
Discontinued › Notes › Leases
us-gaap:OperatingLeasesFutureMinimumPaymentsDueInFourYears · last filed 2020-03-03
- 2018-12-31: Operating Leases, Future Minimum Payments, Due in Four Years $0.00.
- 2018-09-30: Operating Leases, Future Minimum Payments, Due in Four Years $240.00K.
- 2018-06-30: Operating Leases, Future Minimum Payments, Due in Four Years $242.00K.
- 2018-03-31: Operating Leases, Future Minimum Payments, Due in Four Years $255.00K.
| Period end | Operating Leases, Future Minimum Payments, Due in Four Years |
|---|---|
| 2018-12-31 | $0.00 10-K · filed 2020-03-03 |
| 2018-09-30 | $240.00K 10-Q · filed 2018-11-06 |
| 2018-06-30 | $242.00K 10-Q · filed 2018-08-07 |
| 2018-03-31 | $255.00K 10-Q · filed 2018-05-09 |
| 2017-12-31 | $248.00K 10-K · filed 2018-02-26 |
| 2017-09-30 | $245.00K 10-Q · filed 2017-11-07 |
| 2017-06-30 | $237.00K 10-Q · filed 2017-08-09 |
| 2017-03-31 | $221.00K 10-Q · filed 2017-05-09 |
| 2016-12-31 | $2.27M 10-K · filed 2017-02-27 |
| 2016-09-30 | $2.41M 10-Q · filed 2016-11-02 |
| 2016-06-30 | $2.41M 10-Q · filed 2016-08-02 |
| 2016-03-31 | $8.22M 10-Q · filed 2016-05-04 |
| 2015-12-31 | $2.41M 10-K · filed 2016-02-25 |
| 2014-12-31 | $2.10M 10-K · filed 2015-03-13 |
| 2014-09-30 | $2.02M 10-Q · filed 2014-11-04 |
| 2014-06-30 | $2.01M 10-Q · filed 2014-08-05 |
| 2014-03-31 | $2.01M 10-Q · filed 2014-05-05 |
| 2013-12-31 | $2.01M 10-K · filed 2014-03-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| DiaMedica Therapeutics Inc. (DMAC) | United States | $0.423B | -10.11 |
| CYPHERPUNK TECHNOLOGIES INC. (CYPH) | United States | $0.438B | -75.63 |
| Atea Pharmaceuticals, Inc. (AVIR) | United States | $0.414B | -2.26 |
| ARS Pharmaceuticals, Inc. (SPRY) | United States | $0.414B | -3.70 |
| Quoin Pharmaceuticals Ltd. (QNRX) | $0.443B | -17.85 | |
| RELMADA THERAPEUTICS, INC. (RLMD) | United States | $0.406B | -11.92 |
| Opus Genetics, Inc. (IRD) | United States | $0.406B | -3.16 |
| Arcturus Therapeutics Holdings Inc. (ARCT) | $0.402B | -2.05 | |
| GALECTIN THERAPEUTICS INC (GALT) | United States | $0.399B | -11.06 |
| MapLight Therapeutics, Inc. (MPLT) | United States | $0.459B | -7.10 |